fda green list import alert 66-80 glp-1 issues for APIs | Todd Mizeski posted on the topic FDA Launches “Green List” to
Description
Most insurance plans wont cover Ozempic for weight loss, however, they may cover Wegovy which has the same active ingredient, semaglutide
While leg cramps are not typically listed as a primary side effect in clinical trials, they are a frequent topic of conversation among those using GLP-1 medications
It is a way some people use to cope with distress and negative emotions
Individual results may vary, but many patients experience significant weight loss of 5-10% of their body weight or more within a few months of starting treatment
